MEF2A, MEF2C, and MEF2D as potential biomarkers of pancreatic cancer?
Abstract Background The myocyte enhancer factor-2 (MEF2) family genes were involved in the carcinogenesis and prognosis of multiple human tumors. The impact of MEF2s on the occurrences, progression, and clinical outcome of pancreatic cancer (PAAD) remains unknown. Methods This study used the CCLE, H...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-04-01
|
| Series: | BMC Cancer |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12885-025-14107-x |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|